LEXARIA BIOSCIENCE
Lexaria Bioscience Corp. has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. Lexaria’s DehydraTECHTM delivery technology is protected by a robust suite of patents granted or pending worldwide and is proven effective in multiple international studies in greatly assisting rapidity and quantity of absorption of a ... range of lipophilic (i.e., fat-soluble), bioactive molecules. By significantly enhancing the performance and experience with oral ingestion, Lexaria’s DehydraTECH delivery technology offers a viable and often healthier alternative to other delivery methods for bioactive substances in widespread use today such as inhalational delivery through smoking.
LEXARIA BIOSCIENCE
Industry:
Life Science Medical Pharmaceutical
Founded:
2004-01-01
Address:
Kelowna, British Columbia, Canada
Country:
Canada
Website Url:
http://www.lexariabioscience.com
Total Employee:
501+
Status:
Active
Contact:
(250) 765-6424
Total Funding:
13.72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Apache Sitelinks Search Box
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Employees Featured
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2021-04-15 | Lexaria Bioscience appoints Gregory Downey as CFO |
Official Site Inspections
http://www.lexariabioscience.com Semrush global rank: 2.19 M Semrush visits lastest month: 9.01 K
- Host name: 104.21.43.33
- IP address: 104.21.43.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Lexaria Bioscience"
Lexaria Bioscience - A global innovator in drug delivery platforms
Lexaria Bioscience Corp’s (NASDAQ:LEXX, LEXXW) proprietary drug delivery-enabling technology, DehydraTECH™, improves the absorption of active pharmaceutical ingredients …See details»
Company Information - Lexaria Bioscience
Lexaria operates a licensed in-house formulation development and research laboratory and holds a robust intellectual property portfolio with 46 patents granted and many more patents pending worldwide.See details»
Research - Lexaria Bioscience
Lexaria now holds 37 granted patents world-wide. Lexaria to Evaluate Impact of DehydraTECH on Oral Performance of GLP-1 drugs used in products such as Ozempic, Wegovy and Rybelsus, …See details»
Lexaria Bioscience Corp. - Life Sciences British Columbia
Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio. For more information, please visit www.lexariabioscience.com.See details»
Lexaria Bioscience - LinkedIn
Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio and many patents pending worldwide. For more information, please visit...See details»
Lexaria Bioscience Creates and Brands Subsidiary Companies
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of …See details»
Lexaria Bioscience Management Team | Org Chart - RocketReach
DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a …See details»
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer
Mar 14, 2024 · At Rain, Mr. Cabatuan built and led the company's financial organization that experienced significant growth during his tenure. Previously, Mr. Cabatuan served in various …See details»
Lexaria Bioscience Corp. | The Canadian Securities Exchange (CSE)
Oct 28, 2009 · Lexaria Bioscience Corp.'s proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by …See details»
Contact Us - Lexaria Bioscience
Lexaria Bioscience Corp. (NASDAQ:LEXX) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, …See details»
Lexaria Provides Annual Letter From the CEO
Jan 27, 2022 · KELOWNA, BC / ACCESSWIRE / January 27, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug …See details»
Lexaria Bioscience - Overview, News & Similar companies
Apr 11, 2024 · View Lexaria Bioscience (www.lexariabioscience.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar companies as well as …See details»
Investor Relations - Lexaria Bioscience
Lexaria operates a licensed in-house formulation development and research laboratory and holds a robust intellectual property portfolio with 46 patents granted and many more patents pending …See details»
Lexaria's Investigational New Drug Application Filing Update
Dec 7, 2023 · Lexaria is pleased to announce that the supplier in question has updated much of this documentation with Lexaria and directly with the FDA, which will now enable Lexaria to …See details»
Lexaria Bioscience Corp. (NASDAQ: LEXX) to Validate
Jul 22, 2024 · Lexaria’s patented DehydraTECH (TM) “drug delivery platform technology” increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter …See details»
Presentations - Lexaria Bioscience
Nov 20, 2024 · Lexaria Bioscience Corp. (NASDAQ:LEXX) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier …See details»
Lexaria Announces 2022 Annual Meeting Results
Jun 1, 2022 · Lexaria Bioscience Corp.'s patented drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by …See details»
Lexaria Bioscience Corp - Facebook
Lexaria Bioscience Corp. 1,527 likes · 1 talking about this. Lexaria Bioscience Corp is a research-driven company that has developed a patented...See details»
Press Releases Archives - Lexaria Bioscience
Oct 15, 2024 · KELOWNA, BRITISH COLUMBIA / November 14, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug …See details»
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, …
Jan 9, 2024 · Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 37 patents granted and many patents pending worldwide. …See details»